Atopic Dermatitis Treatment Market is on track to achieve a staggering US$ 7.6 Billion in revenue by 2029 | FMI

Atopic Dermatitis Treatment Market

The Atopic Dermatitis Treatment Market was estimated at US$ 5.2 billion in 2021 and is projected to grow at a CAGR of 4.8% between 2022 and 2029, reaching US$ 7.6 billion.

A new market research study by Future Market Insights on the market for atopic dermatitis treatments contains an analysis of the global industry from 2014 to 2021 and an evaluation of the opportunity from 2022 to 2029. For the projected period of 2022–2029, the study analyses the market for atopic dermatitis treatments and offers significant insights. According to the report’s findings, the global market for atopic dermatitis treatments is anticipated to expand significantly over the forecast period as a result of rising prevalence, promising molecules in development, higher treatment compliance, increased access to treatment drugs in developing nations, favourable reimbursement policies, growing government support for R&D, and developing technology.

To Remain Ahead of Your Competitors, Request For A Sample! https://www.futuremarketinsights.com/reports/sample/rep-gb-3097

Corticosteroids Remain the Drug of Choice:

Corticosteroids are referred as the first choice of treatment for the inflammation and pain relief. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling and redness.

Around 30 corticosteroid compounds have been licensed for atopic dermatitis treatment, of which ‘hydrocortisone’ is considered as the first. In addition, increasing innovations have resulted in the advent of topical non-corticosteroids immunomodulators and target medications, for example, immunomodulators such as pimecrolimus and tacrolimus, which in turn, is likely to fuel the growth of the atopic dermatitis treatment market. Moreover, topical corticosteroids are expected to play an important roles in the atopic dermatitis treatment.

North America to Offer High Sales Opportunities:

Growth prospects of the atopic dermatitis treatment market are likely to be high in North America over the forecast period of 2022-2029. Factors such as, greater treatment awareness among the patient population across the United States and Canada, early adoption of novel prescriptions, advanced healthcare infrastructure, better and favorable reimbursement policies, and increasing business associations of pharmaceutical organizations with contract research organizations in developing markets will continue to  propel the atopic dermatitis treatment market growth. Despite the fact that the U.S and Canada deal with heavy investment in healthcare infrastructure as well as per capita expenditure, there are increasing number of campaigns organized each year by specific establishments, for example, National Eczema Associations, the PAN Foundation, and pharmaceutical organizations, which are envisaged to work to the advantage of several market vendors.

Reach Out To Our Analyst And Get All Your Queries Answered! https://www.futuremarketinsights.com/ask-question/rep-gb-3097

Hospital Pharmacies – The Key Distribution Channel for Atopic Dermatitis Treatment:

Sales of medication for atopic dermatitis treatment through hospital pharmacies will continue to account for relatively high share in the market, as they can stock large range of prescription medicines, including progressively specific and investigational medications. Hospital pharmacies may provide a tremendous amount of medications every day, which is distributed to wards and to intensive care units as per the patient’s prescription schedule.

Topical Drug Administration- A Preferred Mode:

Topical mode of administration remains highly preferred among the patient pool of atopic dermatitis. Advent of topical non-corticosteroids immunomodulators is the major factor for the growth in the demand for atopic dermatitis treatment. As topical administration gains prominence, major corticosteroids medications are formulated as topical, in addition to their benefits over oral dosage form.

Atopic Dermatitis Treatment Market: Vendor Insights:

The report highlights some of the prominent market players, who have established themselves as leaders in the global atopic dermatitis treatment market. Some of the examples of key players in the global atopic dermatitis treatment market are Sanofi S.A., Galderma S.A., Allergan Plc., Novartis, Bristol-Myers Squibb, Bayer AG, Meda Pharmaceuticals Inc., Astellas Pharma, Inc., Anacor Pharmaceuticals, Inc., Regeneron Pharmaceuticals, and Valeant Pharmaceuticals International, Inc.

Art of Personalization: Dive into the World of Customization with Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-3097

Atopic Dermatitis Treatment Market by Category:

By Product:

• Corticosteroids
• Calcineurin Inhibitors
• Immunosuppressants
• Biologic Therapy
• PDE-4 Inhibitor
• Antibiotics
• Antihistamines
• Emollients

By Indication:

• Topical
• Oral
• Injectable

 By End-User:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Mail Order Pharmacies
• Dermatology Clinics

By Region

• North America
• Latin America
• Western Europe
• Eastern Europe
• Asia Pacific excluding Japan
• Japan
• Middle East and Africa (MEA)

Get Ahead with Detailed Market Intelligence: Purchase Now to Access! https://www.futuremarketinsights.com/checkout/3097

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube